钠通道
免疫标记
神经病理性疼痛
伤害
角质形成细胞
导航1
红细胞痛
医学
瞬时受体电位通道
伤害感受器
神经科学
细胞生物学
免疫组织化学
内科学
化学
药理学
生物
受体
麻醉
钠
生物化学
体外
有机化学
作者
Peng Zhao,Travis P. Barr,Quanzhi Hou,Sulayman D. Dib‐Hajj,Joel A. Black,Phillip J. Albrecht,Karin L. Petersen,Elon Eisenberg,James Wymer,Frank L. Rice,Stephen G. Waxman
出处
期刊:Pain
[Ovid Technologies (Wolters Kluwer)]
日期:2008-04-29
卷期号:139 (1): 90-105
被引量:176
标识
DOI:10.1016/j.pain.2008.03.016
摘要
Keratinocytes are implicated in sensory transduction and can influence nociception, but whether these contribute to chronic pain is not known. In neurons, voltage-gated sodium channels (Na(v)) are involved in neuropathic pain and are activated by depolarization. Since keratinocytes can also show changes in membrane potential, we used RT-PCR, in situ hybridization, and immunohistochemistry to investigate the expression of sodium channels in these cells. Na(v)1.1, Na(v)1.6, and Na(v)1.8 were localized within keratinocytes in rat epidermis. In addition, sodium channels contribute to the release of ATP from rat keratinocytes in response to increased [K(+)](o), implicating sodium channels in keratinocyte ligand release and nociception. To examine whether keratinocytes may contribute to human pain states, we analyzed sodium channel expression in human skin biopsies from subjects with complex regional pain syndrome Type 1 (CRPS) and post-herpetic neuralgia (PHN) using immunohistochemistry. Control skin exhibited immunolabeling for Na(v)1.5, Na(v)1.6 and Na(v)1.7. In contrast, painful skin from CRPS and PHN subjects displayed Na(v)1.1, Na(v)1.2, and Na(v)1.8 immunolabeling, in addition to substantially increased signal for Na(v)1.5, Na(v)1.6, Na(v)1.7. These observations lead us to propose that pathological increases in keratinocyte sodium channel expression may contribute to pain by increasing epidermal ATP release, resulting in excessive activation of P2X receptors on primary sensory axons. Consistent with this hypothesis, animal models of neuropathic pain exhibit increases in subcutaneous ATP release and activity of primary sensory neurons, and peripheral administration of P2X antagonists has been shown to reduce neuropathic pain in humans.
科研通智能强力驱动
Strongly Powered by AbleSci AI